Food-Derived Longevity Supplement Primeadine® GF Launches at Erewhon
SHERIDAN, Wyo., June 26, 2025 (GLOBE NEWSWIRE) — Oxford Healthspan , a female-founded company dedicated to bringing food-derived longevity compounds to market, announces the launch of Primeadine® GF, its gluten-free spermidine supplement for healthy aging, at Erewhon, an independent, family-owned Certified B Corp and Certified Organic retailer with 10 locations across Southern California .
Spermidine is a naturally occurring molecule that activates autophagy — a mechanism that mimics the effects of fasting by clearing out damaged cells and encouraging the regeneration of healthier ones. It also targets other key drivers of aging, including chronic inflammation, mitochondrial and stem cell dysfunction, and gut microbiome imbalances.
As we age, the body's natural production of spermidine declines, making us more reliant on plant sources in our diet.
Sourced from the longevity islands of Okinawa, Japan, Primeadine GF is a first-of-its-kind, gluten-free spermidine supplement sourced from a unique strain of Okinawan chlorella. It also contains two other autophagy-activating ingredients, nobiletin (from 'Shikuwasa' citrus lime peel) and curcumin (from turmeric).
'We're thrilled to bring Primeadine GF to Erewhon, where customers are deeply intentional about what they put in their bodies,' said Leslie Kenny, CEO and founder of Oxford Healthspan. 'This partnership is especially meaningful because both Oxford Healthspan and Erewhon are rooted in Japanese wellness traditions, from the macrobiotic movement that inspired Erewhon's founding to the Japan-sourced ingredients that power our supplements. We share a commitment to aging well through food-based approaches that honor both science and nature.'
Primeadine GF delivers a range of science-backed benefits: Supports cellular renewal
Promotes cognitive clarity, hormonal balance, and immune resilience
Enhances skin, hair, and nail vitality from the inside out
Backed by Oxford scientists and recommended by leading clinicians and nutritionists
Tested for pesticides, heavy metals and toxins, and free from fillers and flow agents
Primeadine GF is now available at all Erewhon locations across Southern California.
Learn more about Primeadine GF at oxfordhealthspan.com .
About Oxford Healthspan
Oxford Healthspan is a women-led, science-backed longevity supplement company dedicated to helping people age on their own terms by delivering premium, food-derived longevity supplements that harmonize Eastern wisdom with modern longevity science. With a mission to revolutionize healthy aging, Oxford Healthspan sources only the highest-quality ingredients from Japan to ensure purity, potency, and safety. Learn more at oxfordhealthspan.com and follow @oxfordhealthspan on Instagram.
About Erewhon
Erewhon is an independent, family-owned Certified B Corp and Certified Organic Retailer with 10 locations across Southern California. Since 1968, Erewhon has been providing organic, ethically-sourced foods to the communities it serves. It's committed to sourcing healthy, nutrient-dense products, backing local growers and brands, and supporting the environment. Recognized for its uncompromising quality standards and customer service, Erewhon sustains a community centered in caring, curiosity, and positive change. For more information, visit erewhon.com.
MEDIA CONTACT:Lisa Lazarczyk, LAZ PR
Tel: 617.838.7327 or [email protected]
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Ocular Therapeutix™ Unveils New Corporate Branding, Reflecting its Transformation to a Retina-Focused Company
The new branding showcases the Company's innovative vision for the future and mission to redefine the retina experience BEDFORD, Mass., June 26, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, 'Ocular'), a biopharmaceutical company committed to redefining the retina experience, announced the launch of its new corporate branding and website today, marking the next milestone of the Company's transformation to a retina-focused company. Ocular Therapeutix LogoDesigned with visual accessibility at its core, the logo is science-based, transformative, and joyful. The circular 'O' represents the eye and the retina, while the full-spectrum color palette captures the vibrancy of human vision and the richness of life it enables. The treatment of the 'X' represents the intersection of where the company has been and where it is going. 'Retinal disease, including wet age-related macular degeneration (AMD), remains a leading cause of blindness due to the high burden and pulsatile nature of available treatments,' said Pravin U. Dugel, MD, Executive Chairman, President, and CEO of Ocular Therapeutix. 'At Ocular, we aim to redefine the retina experience to reduce that burden in hopes of preserving vision for the long-term. Our new branding reflects the meaningful progress we've made, driven by the momentum of our SOL trials and our commitment to patients.' Ocular Therapeutix Anthem Video Ocular Therapeutix: Retina Experience Redefined A Media Snippet accompanying this announcement is available in this link. Ocular's top priority is to disrupt retinal disease treatment paradigms, starting with wet AMD which affects 1.8 million people in the U.S. alone. Current treatment options may require up to 12 injections per year, creating a heavy burden on patients and care partners that can lead to treatment discontinuation and poor long-term outcomes. With today's pulsatile treatments, one in four patients develop fibrosis within two years and atrophy within five years. Ocular Therapeutix' investigational therapy, AXPAXLI™ (also known as OTX-TKI), is an axitinib hydrogel administered by intravitreal injection that has the potential to dramatically improve durability and long-term outcomes for patients with wet AMD and other retinal diseases. The new corporate branding is now live across Ocular's website, social media channels, and internal platforms, and will make its congress debut at the upcoming American Society of Retina Specialists (ASRS) conference, marking an exciting new chapter for the Company. Explore the new corporate branding on our website. About Ocular Therapeutix, Inc. Ocular Therapeutix, Inc. is a fully-integrated biopharmaceutical company committed to redefining the retina experience. AXPAXLI™ (also known as OTX-TKI), Ocular's investigational product candidate for retinal disease, is an axitinib intravitreal hydrogel based on its ELUTYX™ proprietary bioresorbable hydrogel-based formulation technology. AXPAXLI is currently in Phase 3 clinical trials for wet age-related macular degeneration (wet AMD). Ocular's pipeline also leverages the ELUTYX technology in its commercial product DEXTENZA®, an FDA-approved corticosteroid for the treatment of ocular inflammation and pain following ophthalmic surgery in adults and pediatric patients and ocular itching associated with allergic conjunctivitis in adults and pediatric patients aged two years or older, and in its investigational product candidate OTX-TIC, which is a travoprost intracameral hydrogel that is currently in a Phase 2 clinical trial for the treatment of open-angle glaucoma or ocular hypertension. Follow the Company via its website, LinkedIn, or X. DEXTENZA® is a registered trademark of Ocular Therapeutix, Inc. The Ocular Therapeutix logo, AXPAXLI™, ELUTYX™, and Ocular Therapeutix™ are trademarks of Ocular Therapeutix, Inc. Investors & Media Ocular Therapeutix, Inc. Bill Slattery Vice President, Investor Relations bslattery@ A photo accompanying this announcement is available at in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Miami Herald
an hour ago
- Miami Herald
Red-eyed creature — with ‘needle-like' teeth — is a new species on Japan reef
In the shallow reefs off the coast of southwestern Japan, a small fish scuttles along the rocky seafloor. With colors that blend into the bright coral of the reef, it's just waiting for the opportunity to use its sharp teeth to catch prey. The animal is a lizardfish, part of the fish family Synodontidae, and known for their mottled coloration, lizard-like heads and carnivorous diet. It's also a species new to science. Synodus autumnus, or the autumn lizardfish (Iroha-eso in Japanese), derives its name from its warm-toned coloration, reminiscent of the time when leaves turn orange, yellow and red in the fall, also known as 'iroha' in Japan, according to a study published June 26 in the peer-reviewed journal ZooKeys. One of the fish was caught in a hand net in 2023 about 16 feet below the surface, according to the study. The fish grows to about 2 inches long, researchers said, and has a 'large' mouth filled with 'numerous small, needle-like' teeth. The background color of the fish's body is 'orangish-brown' with a white belly and 'reddish saddle-like blotches' along its back, according to the study. Brown and white blotches create rows along the autumn lizardfish's sides, and the fins have reddish bars on a translucent membrane, researchers said. The fish's iris is orangish-red, matching the color of the saddles, photos show. The new species was originally discovered in Japan, but it also was found to be living in other parts of the Indian and Pacific oceans, according to the study. The fish was found in the waters around Taiwan, the Philippines, Palau, the Marshall Islands, Indonesia, Timor-Leste, Papua New Guinea, Australia, Tonga and Hawaii, researchers said. 'It inhabits inshore areas with coral or rocky reefs and boulders, at depths of (about 3 to 100 feet),' according to the study. Researchers believe the fish may have actually been recorded decades ago in other regions based on underwater photographs, but because they can only be differentiated from another species. S. rubromarmoratus, by examining the teeth and scale lines, photographs alone wouldn't have been enough to identify the fish as a separate species at the time, according to the study. Other records that included drawings were also found but are not considered reliable in the scientific record, researchers said. The autumn lizardfish was found off Kyushu, the southwestern-most large island of Japan. The research team includes Ryusei Furuhashi and Hiroyuki Motomura.
Business Upturn
4 hours ago
- Business Upturn
Food-Derived Longevity Supplement Primeadine® GF Launches at Erewhon
SHERIDAN, Wyo., June 26, 2025 (GLOBE NEWSWIRE) — Oxford Healthspan , a female-founded company dedicated to bringing food-derived longevity compounds to market, announces the launch of Primeadine® GF, its gluten-free spermidine supplement for healthy aging, at Erewhon, an independent, family-owned Certified B Corp and Certified Organic retailer with 10 locations across Southern California . Spermidine is a naturally occurring molecule that activates autophagy — a mechanism that mimics the effects of fasting by clearing out damaged cells and encouraging the regeneration of healthier ones. It also targets other key drivers of aging, including chronic inflammation, mitochondrial and stem cell dysfunction, and gut microbiome imbalances. As we age, the body's natural production of spermidine declines, making us more reliant on plant sources in our diet. Sourced from the longevity islands of Okinawa, Japan, Primeadine GF is a first-of-its-kind, gluten-free spermidine supplement sourced from a unique strain of Okinawan chlorella. It also contains two other autophagy-activating ingredients, nobiletin (from 'Shikuwasa' citrus lime peel) and curcumin (from turmeric). 'We're thrilled to bring Primeadine GF to Erewhon, where customers are deeply intentional about what they put in their bodies,' said Leslie Kenny, CEO and founder of Oxford Healthspan. 'This partnership is especially meaningful because both Oxford Healthspan and Erewhon are rooted in Japanese wellness traditions, from the macrobiotic movement that inspired Erewhon's founding to the Japan-sourced ingredients that power our supplements. We share a commitment to aging well through food-based approaches that honor both science and nature.' Primeadine GF delivers a range of science-backed benefits: Supports cellular renewal Promotes cognitive clarity, hormonal balance, and immune resilience Enhances skin, hair, and nail vitality from the inside out Backed by Oxford scientists and recommended by leading clinicians and nutritionists Tested for pesticides, heavy metals and toxins, and free from fillers and flow agents Primeadine GF is now available at all Erewhon locations across Southern California. Learn more about Primeadine GF at . About Oxford Healthspan Oxford Healthspan is a women-led, science-backed longevity supplement company dedicated to helping people age on their own terms by delivering premium, food-derived longevity supplements that harmonize Eastern wisdom with modern longevity science. With a mission to revolutionize healthy aging, Oxford Healthspan sources only the highest-quality ingredients from Japan to ensure purity, potency, and safety. Learn more at and follow @oxfordhealthspan on Instagram. About Erewhon Erewhon is an independent, family-owned Certified B Corp and Certified Organic Retailer with 10 locations across Southern California. Since 1968, Erewhon has been providing organic, ethically-sourced foods to the communities it serves. It's committed to sourcing healthy, nutrient-dense products, backing local growers and brands, and supporting the environment. Recognized for its uncompromising quality standards and customer service, Erewhon sustains a community centered in caring, curiosity, and positive change. For more information, visit MEDIA CONTACT:Lisa Lazarczyk, LAZ PR Tel: 617.838.7327 or [email protected]
